Ketamine-Assisted Psychotherapy Is FDA Approved

Many of you have been hearing about the wonders of psychedelic therapy and many of you are just now seeing it pop up everywhere without really knowing the breadth of research that has been going on unrelated to recreational use. Here are a few bits of research that might begin to wet your imagination about how Ketamine-Assisted Psychotherapy (KAP) may help you, a friend, or a family member.

Columbia University showed in a five-year-long study that ketamine rapidly reduced depression symptoms, improved cognition, and decreased suicidal thoughts within 24-hours of studied use.

Johns Hopkins Medical Center clinical trials showed ketamine to be highly effective with the 33% of clients who have medication-resistant depression. Wow. That is so great for many of our clients at The Attach Place.

Research from Cornell University suggests ketamine sparks new growth in the brain. Dendrites die off when the brain is under the stress of depression, but research shows that 12-hours after receiving a dose of ketamine, new dendrites begin to grow. This effectively treats depression in a way that no other medication can.

Here @The Attach Place we experience the neuroplasticity from ketamine to expand neuroplasticity within a 72-hour window after the first session.  In that time frame, we provide focused psychotherapy to take advantage of this expansive neuroplasticity to help you change your thinking and the limiting belief systems that hold you back from being healthy, feeling happy, and living your best, whole life. If you have questions, we are here for you.

Leave a Comment